178 related articles for article (PubMed ID: 22904680)
1. The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform.
Cattelani S; Ferrari-Amorotti G; Galavotti S; Defferrari R; Tanno B; Cialfi S; Vergalli J; Fragliasso V; Guerzoni C; Manzotti G; Soliera AR; Menin C; Bertorelle R; McDowell HP; Inserra A; Belli ML; Varesio L; Tweddle D; Tonini GP; Altavista P; Dominici C; Raschellà G; Calabretta B
Neoplasia; 2012 Jul; 14(7):634-43. PubMed ID: 22904680
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs.
Vikhanskaya F; Siddique MM; Kei Lee M; Broggini M; Sabapathy K
Clin Cancer Res; 2005 Jun; 11(12):4348-56. PubMed ID: 15958617
[TBL] [Abstract][Full Text] [Related]
3. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India.
Bansal A; Das P; Kannan S; Mahantshetty U; Mulherkar R
Indian J Med Res; 2016 Sep; 144(3):359-365. PubMed ID: 28139534
[TBL] [Abstract][Full Text] [Related]
4. Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression.
Carr-Wilkinson J; Griffiths R; Elston R; Gamble LD; Goranov B; Redfern CP; Lunec J; Tweddle DA
Cell Cycle; 2011 Nov; 10(21):3778-87. PubMed ID: 22052359
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells.
Lee YJ; Chang WW; Chang CP; Liu TY; Chuang CY; Qian K; Zheng YG; Li C
Sci Rep; 2019 Feb; 9(1):1771. PubMed ID: 30741995
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
[TBL] [Abstract][Full Text] [Related]
8. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
Kumari A; Bahl C; Singh N; Behera D; Sharma S
Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
[TBL] [Abstract][Full Text] [Related]
9. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
Chen RH; Chang CT; Wang TY; Huang WL; Tsai CH; Tsai FJ
J Clin Lab Anal; 2008; 22(5):321-6. PubMed ID: 18803266
[TBL] [Abstract][Full Text] [Related]
10. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
[TBL] [Abstract][Full Text] [Related]
11. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
[TBL] [Abstract][Full Text] [Related]
12. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
[TBL] [Abstract][Full Text] [Related]
13. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
14. Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.
Jiang J; Chen HN; Jin P; Zhou L; Peng L; Huang Z; Qin S; Li B; Ming H; Luo M; Xie N; Gao W; Nice EC; Yu Q; Huang C
Signal Transduct Target Ther; 2023 Feb; 8(1):65. PubMed ID: 36788227
[TBL] [Abstract][Full Text] [Related]
15. Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma.
Xie X; Wang H; Jin H; Ouyang S; Zhou J; Hu J; Xi X; Luo J; Zhang Y; Hu B
Radiat Oncol; 2013 May; 8():117. PubMed ID: 23663243
[TBL] [Abstract][Full Text] [Related]
16. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.
Siddique M; Sabapathy K
Oncogene; 2006 Jun; 25(25):3489-500. PubMed ID: 16462765
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection and a P53 codon 72 single nucleotide polymorphism: a reason for an unexplained Asian enigma.
Pandey R; Misra V; Misra SP; Dwivedi M; Misra A
Asian Pac J Cancer Prev; 2014; 15(21):9171-6. PubMed ID: 25422197
[TBL] [Abstract][Full Text] [Related]
18. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer.
McGregor JM; Harwood CA; Brooks L; Fisher SA; Kelly DA; O'nions J; Young AR; Surentheran T; Breuer J; Millard TP; Lewis CM; Leigh IM; Storey A; Crook T
J Invest Dermatol; 2002 Jul; 119(1):84-90. PubMed ID: 12164929
[TBL] [Abstract][Full Text] [Related]
19. p53 is a direct transcriptional target of MYCN in neuroblastoma.
Chen L; Iraci N; Gherardi S; Gamble LD; Wood KM; Perini G; Lunec J; Tweddle DA
Cancer Res; 2010 Feb; 70(4):1377-88. PubMed ID: 20145147
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.
Veschi V; Petroni M; Cardinali B; Dominici C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Giannini G
PLoS One; 2012; 7(11):e49139. PubMed ID: 23152863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
